Heart Rhythm: FDA approves extravascular ICD | AI spots AFib in asymptomatic patients | Treating sudden cardiac arrest

The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.

All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

The study included ECG data from more than 900,000 U.S. veterans.

Researchers hopes this first-in-class gene therapy, known as TN-201, can restore the patient’s MYBPC3 levels and eventually lead to disease reversal.

Preventing sudden cardiac arrest involves managing risk factors such as hypertension, hyperlipidemia and diabetes. We spoke to Christine Albert, MD, about this and much more at ESC 2023.

A majority of patient deaths within two years of TAVR can be linked to cardiovascular complications, according to new research published in JACC: Cardiovascular Interventions. Can follow-up care be improved to combat this trend? 

Asking patients to use smartphone-powered ECG devices following catheter ablation procedures could be incredibly beneficial, according to new findings published in JACC: Clinical Electrophysiology. 

Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures.